Drugs
November 2008: Additions and Deletions to the Drug Product List
28th Edition: Cumulative Supplement Number 11
NOTE: The format for the Monthly Additions/Deletions Drug Product List changed as of the July Cumulative Supplement (CS) of the 21st Edition to mirror the CS. Refer to the CS Preface section 1.6 Cumulative Supplement Legend.
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST
ACETAMINOPHEN; BUTALBITAL; CAFFEINE TABLET; ORAL BUTALBITAL ACETAMINOPHEN AND CAFFEINE >A> AB CONCORD LABS NJ 325MG;50MG;40MG N40864 001 Dec 01, 2008 Nov NEWA ACETAMINOPHEN; CODEINE PHOSPHATE TABLET; ORAL CODRIX >D> @ ANDRX PHARMS 500MG;30MG N40441 001 Mar 27, 2003 Nov CAHN >A> @ WATSON LABS 500MG;30MG N40441 001 Mar 27, 2003 Nov CAHN ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE TABLET; ORAL PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN >D> AB ANDRX PHARMS 500MG;100MG N77196 001 Jun 28, 2005 Nov CAHN >A> AB WATSON LABS 500MG;100MG N77196 001 Jun 28, 2005 Nov CAHN ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE; ORAL >A> ACETAZOLAMIDE >A> AB ZYDUS PHARMS 500MG N40904 001 Dec 10, 2008 Nov NEWA DIAMOX >D> + DURAMED PHARMS 500MG N12945 001 Nov CFTG >A> AB + 500MG N12945 001 Nov CFTG ACETAZOLAMIDE SODIUM INJECTABLE; INJECTION ACETAZOLAMIDE SODIUM >A> AP X GEN PHARMS EQ 500MG BASE/VIAL N40784 001 Dec 10, 2008 Nov NEWA ALBUTEROL SULFATE SOLUTION; INHALATION ALBUTEROL SULFATE >A> AN LANNETT EQ 0.083% BASE N77839 001 Dec 16, 2008 Nov NEWA ALPRAZOLAM TABLET; ORAL ALPRAZOLAM >A> AB VINTAGE 2MG N78491 004 Dec 12, 2008 Nov NEWA AMOXICILLIN; CLAVULANATE POTASSIUM FOR SUSPENSION; ORAL >A> AMOXICILLIN AND CLAVULANATE POTASSIUM >A> AB MORTON GROVE 250MG/5ML;EQ 62.5MG BASE/5ML N65431 001 Nov 25, 2008 Nov NEWA AUGMENTIN '250' >D> + GLAXOSMITHKLINE 250MG/5ML;EQ 62.5MG BASE/5ML N50575 002 Aug 06, 1984 Nov CFTG >A> AB + 250MG/5ML;EQ 62.5MG BASE/5ML N50575 002 Aug 06, 1984 Nov CFTG AMPICILLIN/AMPICILLIN TRIHYDRATE FOR SUSPENSION; ORAL AMPICILLIN TRIHYDRATE >D> AB CLONMEL EQ 250MG BASE/5ML N62982 002 Feb 10, 1989 Nov CRLD >A> + EQ 250MG BASE/5ML N62982 002 Feb 10, 1989 Nov CRLD ARGATROBAN INJECTABLE; INJECTION ARGATROBAN >D> + ENCYSIVE 100MG/ML N20883 001 Jun 30, 2000 Nov CAHN >A> + PFIZER 100MG/ML N20883 001 Jun 30, 2000 Nov CAHN BETAMETHASONE VALERATE CREAM; TOPICAL BETAMETHASONE VALERATE >D> AB TARO EQ 0.1% BASE N70062 001 May 14, 1985 Nov DISC >A> @ EQ 0.1% BASE N70062 001 May 14, 1985 Nov DISC LOTION; TOPICAL BETAMETHASONE VALERATE >D> AB ACTAVIS MID EQ 0.1% BASE N70052 001 Jul 31, 1985 Nov CAHN >A> AB STAT-TRADE EQ 0.1% BASE N70052 001 Jul 31, 1985 Nov CAHN BUDESONIDE SUSPENSION; INHALATION >A> BUDESONIDE >A> AN IVAX PHARMS INC 0.25MG/2ML N77519 001 Nov 18, 2008 Nov NEWA >A> AN 0.5MG/2ML N77519 002 Nov 18, 2008 Nov NEWA PULMICORT RESPULES >D> ASTRAZENECA 0.25MG/2ML N20929 001 Aug 08, 2000 Nov CFTG >A> AN 0.25MG/2ML N20929 001 Aug 08, 2000 Nov CFTG >D> 0.5MG/2ML N20929 002 Aug 08, 2000 Nov CFTG >A> AN 0.5MG/2ML N20929 002 Aug 08, 2000 Nov CFTG BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE; ORAL BUPROPION HYDROCHLORIDE >A> AB3 ACTAVIS 150MG N77285 001 Nov 26, 2008 Nov NEWA >A> AB3 IMPAX LABS 150MG N77415 001 Nov 26, 2008 Nov NEWA >A> AB3 WATSON LABS 150MG N77715 001 Nov 26, 2008 Nov NEWA CALCIUM ACETATE TABLET; ORAL ELIPHOS >A> + CYPRESS PHARM EQ 169MG CALCIUM N78502 001 Nov 25, 2008 Nov NEWA CARBOPLATIN INJECTABLE; IV (INFUSION) CARBOPLATIN >A> AP PLIVA LACHEMA EQ 50MG/5ML (10MG/ML) N78631 001 Dec 02, 2008 Nov NEWA >A> AP EQ 150MG/15ML (10MG/ML) N78631 002 Dec 02, 2008 Nov NEWA >A> AP EQ 450MG/45ML (10MG/ML) N78631 003 Dec 02, 2008 Nov NEWA >A> AP EQ 600MG/60ML (10MG/ML) N78631 004 Dec 02, 2008 Nov NEWA CETIRIZINE HYDROCHLORIDE SYRUP; ORAL >D> CERTIRIZINE HYDROCHLORIDE >D> AA TEVA PHARMS 5MG/5ML N77279 001 May 27, 2008 Nov CTNA >A> CETIRIZINE HYDROCHLORIDE >A> AA TEVA PHARMS 5MG/5ML N77279 001 May 27, 2008 Nov CTNA CEVIMELINE HYDROCHLORIDE CAPSULE; ORAL EVOXAC >D> + DAIICHI EQ 30MG BASE N20989 002 Jan 11, 2000 Nov CAHN >A> + DAIICHI SANKYO CO EQ 30MG BASE N20989 002 Jan 11, 2000 Nov CAHN CIPROFLOXACIN HYDROCHLORIDE SOLUTION/DROPS; OPHTHALMIC CIPROFLOXACIN HYDROCHLORIDE >A> AT AKORN INC EQ 0.3% BASE N76555 001 Dec 11, 2008 Nov NEWA CITALOPRAM HYDROBROMIDE TABLET; ORAL CITALOPRAM HYDROBROMIDE >D> AB TARO EQ 10MG BASE N77278 001 Mar 22, 2006 Nov DISC >A> @ EQ 10MG BASE N77278 001 Mar 22, 2006 Nov DISC >D> AB EQ 20MG BASE N77278 002 Mar 22, 2006 Nov DISC >A> @ EQ 20MG BASE N77278 002 Mar 22, 2006 Nov DISC >D> AB EQ 40MG BASE N77278 003 Mar 22, 2006 Nov DISC >A> @ EQ 40MG BASE N77278 003 Mar 22, 2006 Nov DISC CLOBETASOL PROPIONATE LOTION; TOPICAL >A> CLOBETASOL PROPIONATE >A> AB ACTAVIS MID 0.05% N78223 001 Dec 04, 2008 Nov NEWA CLOBEX >D> + GALDERMA LABS LP 0.05% N21535 001 Jul 24, 2003 Nov CFTG >A> AB + 0.05% N21535 001 Jul 24, 2003 Nov CFTG CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE SYRUP; ORAL TRIACIN-C >D> + ACTAVIS MID 10MG/5ML;30MG/5ML;1.25MG/5ML N88704 001 Mar 22, 1985 Nov CAHN >A> + STAT-TRADE 10MG/5ML;30MG/5ML;1.25MG/5ML N88704 001 Mar 22, 1985 Nov CAHN DEMECLOCYCLINE HYDROCHLORIDE TABLET; ORAL DEMECLOCYCLINE HYDROCHLORIDE >A> AB COVENANT 150MG N65389 001 Dec 01, 2008 Nov NEWA >A> AB 300MG N65389 002 Dec 01, 2008 Nov NEWA DEXAMETHASONE ELIXIR; ORAL DEXAMETHASONE >D> AA + ACTAVIS MID 0.5MG/5ML N84754 001 Nov CAHN >A> AA + STAT-TRADE 0.5MG/5ML N84754 001 Nov CAHN DIFLUNISAL TABLET; ORAL DIFLUNISAL >D> AB TEVA 500MG N73673 001 Jul 31, 1992 Nov CRLD >A> AB + 500MG N73673 001 Jul 31, 1992 Nov CRLD DILTIAZEM HYDROCHLORIDE INJECTABLE; INJECTION DILTIAZEM HYDROCHLORIDE >A> AP BAXTER HLTHCARE 5MG/ML N78538 001 Dec 17, 2008 Nov NEWA DIVALPROEX SODIUM TABLET, DELAYED RELEASE; ORAL DIVALPROEX SODIUM >A> AB ORCHID HLTHCARE EQ 125MG VALPROIC ACID N78853 001 Nov 25, 2008 Nov NEWA >A> AB EQ 250MG VALPROIC ACID N78853 002 Nov 25, 2008 Nov NEWA >A> AB EQ 500MG VALPROIC ACID N78853 003 Nov 25, 2008 Nov NEWA DORZOLAMIDE HYDROCHLORIDE SOLUTION/DROPS; OPHTHALMIC DORZOLAMIDE HYDROCHLORIDE >A> AT TEVA PHARMS EQ 2% BASE N78756 001 Dec 04, 2008 Nov NEWA ECHOTHIOPHATE IODIDE FOR SOLUTION; OPHTHALMIC PHOSPHOLINE IODIDE >D> @ AYERST 0.03% N11963 002 Nov CAHN >D> @ 0.06% N11963 004 Nov CAHN >D> + 0.125% N11963 001 Nov CAHN >D> @ 0.25% N11963 003 Nov CAHN >A> @ WYETH PHARMS 0.03% N11963 002 Nov CAHN >A> @ 0.06% N11963 004 Nov CAHN >A> + 0.125% N11963 001 Nov CAHN >A> @ 0.25% N11963 003 Nov CAHN EDROPHONIUM CHLORIDE INJECTABLE; INJECTION ENLON >D> @ BAXTER HLTHCARE 10MG/ML N88873 001 Aug 06, 1985 Nov CAHN >A> @ BIONICHE PHARMA 10MG/ML N88873 001 Aug 06, 1985 Nov CAHN >A> ELTROMBOPAG OLAMINE >A> TABLET; ORAL >A> PROMACTA >A> GLAXOSMITHKLINE EQ 25MG ACID N22291 001 Nov 20, 2008 Nov NEWA >A> + EQ 50MG ACID N22291 002 Nov 20, 2008 Nov NEWA ERYTHROMYCIN SOLUTION; TOPICAL >D> A/T/S >D> AT TARO PHARMS 2% N62405 001 Nov 18, 1982 Nov DISC >A> @ 2% N62405 001 Nov 18, 1982 Nov DISC ESTROGENS, CONJUGATED SYNTHETIC A CREAM; VAGINAL >A> SYNTHETIC CONJUGATED ESTROGENS A >A> + DURAMED 0.625MG/GM N21788 001 Nov 28, 2008 Nov NEWA ETHINYL ESTRADIOL; NORETHINDRONE TABLET; ORAL-21 >D> BREVICON 21-DAY >D> AB + WATSON LABS 0.035MG;0.5MG N17566 001 Nov DISC >A> @ 0.035MG;0.5MG N17566 001 Nov DISC NORETHINDRONE AND ETHINYL ESTRADIOL >D> AB WATSON LABS 0.035MG;0.5MG N70684 001 Jan 29, 1987 Nov DISC >A> @ 0.035MG;0.5MG N70684 001 Jan 29, 1987 Nov DISC TABLET; ORAL-28 MODICON 28 >D> AB ORTHO MCNEIL 0.035MG;0.5MG N17735 001 Nov CRLD >A> AB + 0.035MG;0.5MG N17735 001 Nov CRLD ETODOLAC TABLET, EXTENDED RELEASE; ORAL ETODOLAC >D> @ ANDRX PHARMS 400MG N75829 001 Nov 30, 2001 Nov CAHN >D> @ 500MG N75829 002 Nov 30, 2001 Nov CAHN >A> @ WATSON LABS 400MG N75829 001 Nov 30, 2001 Nov CAHN >A> @ 500MG N75829 002 Nov 30, 2001 Nov CAHN FINASTERIDE TABLET; ORAL FINASTERIDE >D> AB IVAX PHARMS 5MG N76340 001 Jun 19, 2006 Nov DISC >A> @ 5MG N76340 001 Jun 19, 2006 Nov DISC GALANTAMINE HYDROBROMIDE CAPSULE, EXTENDED RELEASE; ORAL GALANTAMINE HYDROBROMIDE >A> AB DANBURY PHARMA EQ 8MG BASE N79028 001 Dec 15, 2008 Nov NEWA >A> AB EQ 16MG BASE N79028 002 Dec 15, 2008 Nov NEWA >A> AB EQ 24MG BASE N79028 003 Dec 15, 2008 Nov NEWA GEMCITABINE HYDROCHLORIDE INJECTABLE; INJECTION >A> GEMCITABINE HYDROCHLORIDE >A> AP TEVA PARENTERAL EQ 200MG BASE/VIAL N77961 001 Dec 18, 2008 Nov NEWA >A> AP EQ 1GM BASE/VIAL N77983 001 Dec 18, 2008 Nov NEWA GEMZAR >D> + LILLY EQ 200MG BASE/VIAL N20509 001 May 15, 1996 Nov CFTG >A> AP + EQ 200MG BASE/VIAL N20509 001 May 15, 1996 Nov CFTG >D> + EQ 1GM BASE/VIAL N20509 002 May 15, 1996 Nov CFTG >A> AP + EQ 1GM BASE/VIAL N20509 002 May 15, 1996 Nov CFTG HYDRALAZINE HYDROCHLORIDE TABLET; ORAL HYDRALAZINE HYDROCHLORIDE >A> AA INVAGEN PHARMS 10MG N90255 001 Dec 15, 2008 Nov NEWA >A> AA 25MG N90255 002 Dec 15, 2008 Nov NEWA >A> AA 50MG N90255 003 Dec 15, 2008 Nov NEWA >A> AA 100MG N90255 004 Dec 15, 2008 Nov NEWA HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE CAPSULE; ORAL HYDRA-ZIDE >D> AB PAR PHARM 25MG;25MG N88957 001 Oct 21, 1985 Nov CTEC >A> 25MG;25MG N88957 001 Oct 21, 1985 Nov CTEC >D> AB 50MG;50MG N88946 001 Oct 21, 1985 Nov CRLD >A> + 50MG;50MG N88946 001 Oct 21, 1985 Nov CRLD HYDROCODONE BITARTRATE; IBUPROFEN TABLET; ORAL REPREXAIN >D> @ AMNEAL PHARMS 2.5MG;200MG N76642 003 Oct 19, 2007 Nov CMFD >A> 2.5MG;200MG N76642 003 Oct 19, 2007 Nov CMFD >D> @ 10MG;200MG N76642 004 Oct 19, 2007 Nov CMFD >A> + 10MG;200MG N76642 004 Oct 19, 2007 Nov CMFD IBUPROFEN SUSPENSION; ORAL MOTRIN >A> AB + MCNEIL CONS 100MG/5ML N19842 001 Sep 19, 1989 Nov CAHN >D> AB + MCNEIL PED 100MG/5ML N19842 001 Sep 19, 1989 Nov CAHN TABLET; ORAL IBUPROFEN >D> AB MUTUAL PHARM 300MG N71230 001 Oct 22, 1986 Nov CAHN >D> AB 400MG N71231 001 Oct 22, 1986 Nov CAHN >D> AB 600MG N71232 001 Oct 22, 1986 Nov CAHN >D> AB 800MG N72004 001 Nov 18, 1987 Nov CAHN >A> AB VINTAGE PHARMS 300MG N71230 001 Oct 22, 1986 Nov CAHN >A> AB 400MG N71231 001 Oct 22, 1986 Nov CAHN >A> AB 600MG N71232 001 Oct 22, 1986 Nov CAHN >A> AB 800MG N72004 001 Nov 18, 1987 Nov CAHN MOTRIN >A> MCNEIL CONS 300MG N17463 003 Nov DISC >A> AB 400MG N17463 002 Nov CAHN >A> AB 600MG N17463 004 Nov CAHN >A> AB + 800MG N17463 005 May 22, 1985 Nov CAHN >D> AB MCNEIL PED 300MG N17463 003 Nov DISC >D> AB 400MG N17463 002 Nov CAHN >D> AB 600MG N17463 004 Nov CAHN >D> AB + 800MG N17463 005 May 22, 1985 Nov CAHN >D> INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT >D> INJECTABLE; SUBCUTANEOUS >D> NOVOLOG MIX 50/50 >D> + NOVO NORDISK INC 50 UNITS/ML;50 UNITS/ML N21810 001 Aug 26, 2008 Nov DISC >A> @ 50 UNITS/ML;50 UNITS/ML N21810 001 Aug 26, 2008 Nov DISC IOPROMIDE INJECTABLE; INJECTION ULTRAVIST 300 IN PLASTIC CONTAINER >A> + BAYER HLTHCARE 62.3% N20220 005 Nov 18, 2008 Nov NEWA IRINOTECAN HYDROCHLORIDE INJECTABLE; INJECTION IRINOTECAN HYDROCHLORIDE >A> AP ACCORD 40MG/2ML (20MG/ML) N79068 001 Nov 21, 2008 Nov NEWA >A> AP 100MG/5ML (20MG/ML) N79068 002 Nov 21, 2008 Nov NEWA >A> AP TEVA PARENTERAL 500MG/25ML (20MG/ML) N90101 001 Nov 26, 2008 Nov NEWA LACTULOSE SOLUTION; ORAL, RECTAL LACTULOSE >A> AA ANI PHARMS INC 10GM/15ML N90426 001 Nov 21, 2008 Nov NEWA LEVOTHYROXINE SODIUM** TABLET; ORAL NOVOTHYROX >D> @ GENPHARM 0.025MG N21292 001 May 31, 2002 Nov CAHN >D> @ 0.05MG N21292 002 May 31, 2002 Nov CAHN >D> @ 0.075MG N21292 003 May 31, 2002 Nov CAHN >D> @ 0.088MG N21292 004 May 31, 2002 Nov CAHN >D> @ 0.1MG N21292 005 May 31, 2002 Nov CAHN >D> @ 0.112MG N21292 006 May 31, 2002 Nov CAHN >D> @ 0.125MG N21292 007 May 31, 2002 Nov CAHN >D> @ 0.137MG N21292 008 May 31, 2002 Nov CAHN >D> @ 0.15MG N21292 009 May 31, 2002 Nov CAHN >D> @ 0.175MG N21292 010 May 31, 2002 Nov CAHN >D> @ 0.2MG N21292 011 May 31, 2002 Nov CAHN >D> @ 0.3MG N21292 012 May 31, 2002 Nov CAHN >A> @ MERCK KGAA 0.025MG N21292 001 May 31, 2002 Nov CAHN >A> @ 0.05MG N21292 002 May 31, 2002 Nov CAHN >A> @ 0.075MG N21292 003 May 31, 2002 Nov CAHN >A> @ 0.088MG N21292 004 May 31, 2002 Nov CAHN >A> @ 0.1MG N21292 005 May 31, 2002 Nov CAHN >A> @ 0.112MG N21292 006 May 31, 2002 Nov CAHN >A> @ 0.125MG N21292 007 May 31, 2002 Nov CAHN >A> @ 0.137MG N21292 008 May 31, 2002 Nov CAHN >A> @ 0.15MG N21292 009 May 31, 2002 Nov CAHN >A> @ 0.175MG N21292 010 May 31, 2002 Nov CAHN >A> @ 0.2MG N21292 011 May 31, 2002 Nov CAHN >A> @ 0.3MG N21292 012 May 31, 2002 Nov CAHN METAPROTERENOL SULFATE >D> AEROSOL, METERED; INHALATION >D> ALUPENT >D> + BOEHRINGER 0.65MG/INH N16402 001 Nov DISC >A> @ 0.65MG/INH N16402 001 Nov DISC SOLUTION; INHALATION METAPROTERENOL SULFATE >D> AN DEY 0.4% N71786 001 Aug 05, 1988 Nov CRLD >A> AN + 0.4% N71786 001 Aug 05, 1988 Nov CRLD >D> AN 0.6% N70804 001 Aug 17, 1987 Nov CRLD >A> AN + 0.6% N70804 001 Aug 17, 1987 Nov CRLD METFORMIN HYDROCHLORIDE TABLET; ORAL METFORMIN HYDROCHLORIDE >A> AB INDICUS PHARMA 500MG N79148 001 Nov 25, 2008 Nov NEWA >A> AB 850MG N79148 002 Nov 25, 2008 Nov NEWA >A> AB 1GM N79148 003 Nov 25, 2008 Nov NEWA METHYLERGONOVINE MALEATE INJECTABLE; INJECTION METHERGINE >D> + NOVARTIS 0.2MG/ML N06035 004 Nov CFTG >A> AP + 0.2MG/ML N06035 004 Nov CFTG >A> METHYLERGONOVINE MALEATE >A> AP PHARMAFORCE 0.2MG/ML N90193 001 Nov 24, 2008 Nov NEWA METHYLPREDNISOLONE SODIUM SUCCINATE INJECTABLE; INJECTION A-METHAPRED >A> AP HEMOPHARM USA EQ 40MG BASE/VIAL N40793 001 Nov 25, 2008 Nov NEWA >A> AP EQ 125MG BASE/VIAL N40827 001 Nov 25, 2008 Nov NEWA MIRTAZAPINE TABLET; ORAL MIRTAZAPINE >D> AB IVAX PHARMS 15MG N76244 001 Dec 22, 2003 Nov DISC >A> @ 15MG N76244 001 Dec 22, 2003 Nov DISC >D> AB 30MG N76244 002 Dec 22, 2003 Nov DISC >A> @ 30MG N76244 002 Dec 22, 2003 Nov DISC >D> AB 45MG N76244 003 Dec 22, 2003 Nov DISC >A> @ 45MG N76244 003 Dec 22, 2003 Nov DISC NAPROXEN SODIUM TABLET, EXTENDED RELEASE; ORAL NAPRELAN >D> @ STAT TRADE EQ 750MG BASE N20353 003 Jan 05, 1996 Nov CMFD >A> EQ 750MG BASE N20353 003 Jan 05, 1996 Nov CMFD NEDOCROMIL SODIUM >D> AEROSOL, METERED; INHALATION >D> TILADE >D> + KING PHARMS 1.75MG/INH N19660 001 Dec 30, 1992 Nov DISC >A> @ 1.75MG/INH N19660 001 Dec 30, 1992 Nov DISC OFLOXACIN SOLUTION/DROPS; OPHTHALMIC OFLOXACIN >A> AT SANDOZ 0.3% N76848 001 Nov 25, 2008 Nov NEWA ONDANSETRON HYDROCHLORIDE INJECTABLE; INJECTION ONDANSETRON HYDROCHLORIDE >A> AP LUITPOLD EQ 2MG BASE/ML N79039 001 Nov 18, 2008 Nov NEWA >A> AP ONLUITPOLD REEQ 2MG BASE/ML N79032 001 Nov 18, 2008 Nov NEWA PALONOSETRON HYDROCHLORIDE INJECTABLE; INTRAVENOUS ALOXI >D> HELSINN HLTHCARE EQ 0.075MG BASE/1.5ML (EQ 0.05MG N21372 002 Feb 29, 2008 Nov CRLD >A> + EQ 0.075MG BASE/1.5ML (EQ 0.05MG N21372 002 Feb 29, 2008 Nov CRLD PAMIDRONATE DISODIUM INJECTABLE; INJECTION PAMIDRONATE DISODIUM >A> AP CIPLA LTD 30MG/VIAL N77433 001 Nov 26, 2008 Nov NEWA >A> AP 60MG/VIAL N77433 002 Nov 26, 2008 Nov NEWA >A> AP 90MG/VIAL N77433 003 Nov 26, 2008 Nov NEWA PAROXETINE HYDROCHLORIDE TABLET; ORAL PAROXETINE HYDROCHLORIDE >A> AB APOTEX EQ 10MG BASE N75356 001 Jul 30, 2003 Nov CAHN >A> AB EQ 20MG BASE N75356 002 Jul 30, 2003 Nov CAHN >A> AB EQ 30MG BASE N75356 003 Jul 30, 2003 Nov CAHN >A> AB EQ 40MG BASE N75356 004 Jul 30, 2003 Nov CAHN >D> AB TORPHARM EQ 10MG BASE N75356 001 Jul 30, 2003 Nov CAHN >D> AB EQ 20MG BASE N75356 002 Jul 30, 2003 Nov CAHN >D> AB EQ 30MG BASE N75356 003 Jul 30, 2003 Nov CAHN >D> AB EQ 40MG BASE N75356 004 Jul 30, 2003 Nov CAHN POTASSIUM CHLORIDE CAPSULE, EXTENDED RELEASE; ORAL POTASSIUM CHLORIDE >D> AB ANDRX PHARMS 8MEQ N77419 001 Jun 02, 2008 Nov CAHN >D> AB 10MEQ N77419 002 Jun 02, 2008 Nov CAHN >A> AB WATSON LABS 8MEQ N77419 001 Jun 02, 2008 Nov CAHN >A> AB 10MEQ N77419 002 Jun 02, 2008 Nov CAHN RANITIDINE HYDROCHLORIDE TABLET; ORAL RANITIDINE HYDROCHLORIDE >A> AB GLENMARK EQ 150MG BASE N78542 001 Nov 19, 2008 Nov NEWA >A> AB EQ 300MG BASE N78542 002 Nov 19, 2008 Nov NEWA RISPERIDONE TABLET; ORAL RISPERIDONE >A> AB COBALT LABS INC 0.25MG N77860 001 Dec 05, 2008 Nov NEWA >A> AB 0.5MG N77860 002 Dec 05, 2008 Nov NEWA >A> AB 1MG N77860 003 Dec 05, 2008 Nov NEWA >A> AB 2MG N77860 004 Dec 05, 2008 Nov NEWA >A> AB 3MG N77860 005 Dec 05, 2008 Nov NEWA >A> AB 4MG N77860 006 Dec 05, 2008 Nov NEWA ROCURONIUM BROMIDE INJECTABLE; INJECTION >A> ROCURONIUM BROMIDE >A> AP GENERAMEDIX 50MG/5ML(10MG/ML) N79199 001 Nov 26, 2008 Nov NEWA >A> AP 100MG/10ML(10MG/ML) N79199 002 Nov 26, 2008 Nov NEWA >A> AP HOSPIRA 50MG/5ML(10MG/ML) N78519 001 Nov 26, 2008 Nov NEWA >A> AP 100MG/10ML(10MG/ML) N78519 002 Nov 26, 2008 Nov NEWA >A> AP SANDOZ 50MG/5ML (10MG/ML) N79195 001 Dec 05, 2008 Nov NEWA >A> AP 100MG/10ML (10MG/ML) N79195 002 Dec 05, 2008 Nov NEWA >A> AP TEVA PARENTERAL 50MG/5ML(10MG/ML) N78717 001 Nov 26, 2008 Nov NEWA >A> AP 100MG/ML(10MG/ML) N78717 002 Nov 26, 2008 Nov NEWA ZEMURON >D> + ORGANON USA INC 50MG/5ML(10MG/ML) N20214 001 Mar 17, 1994 Nov CFTG >A> AP + 50MG/5ML(10MG/ML) N20214 001 Mar 17, 1994 Nov CFTG >D> + 100MG/10ML(10MG/ML) N20214 003 Mar 17, 1994 Nov CFTG >A> AP + 100MG/10ML(10MG/ML) N20214 003 Mar 17, 1994 Nov CFTG RUFINAMIDE TABLET; ORAL BANZEL >A> @ EISAI MEDCL RES 100MG N21911 001 Nov 14, 2008 Nov DISC >A> 200MG N21911 002 Nov 14, 2008 Nov NEWA >A> + 400MG N21911 003 Nov 14, 2008 Nov NEWA SODIUM POLYSTYRENE SULFONATE POWDER; ORAL, RECTAL SODIUM POLYSTYRENE SULFONATE >A> AA NOVEL LABS INC 454GM/BOT N40909 001 Dec 03, 2008 Nov NEWA SULFACETAMIDE SODIUM SOLUTION/DROPS; OPHTHALMIC BLEPH-30 >D> AT + ALLERGAN 30% N80028 002 Nov DISC >A> @ 30% N80028 002 Nov DISC SULINDAC TABLET; ORAL SULINDAC >A> @ EPIC PHARMA 150MG N72710 001 Mar 25, 1991 Nov CAHN >A> @ 200MG N72711 001 Mar 25, 1991 Nov CAHN >D> @ WARNER CHILCOTT 150MG N72710 001 Mar 25, 1991 Nov CAHN >D> @ 200MG N72711 001 Mar 25, 1991 Nov CAHN >A> TAPENTADOL HYDROCHLORIDE >A> TABLET; ORAL >A> TAPENTADOL HYDROCHLORIDE >A> ORTHO MCNEIL 50MG N22304 001 Nov 20, 2008 Nov NEWA >A> 75MG N22304 002 Nov 20, 2008 Nov NEWA >A> + 100MG N22304 003 Nov 20, 2008 Nov NEWA >D> TETRACYCLINE PHOSPHATE COMPLEX >D> CAPSULE; ORAL >D> TETREX >D> BRISTOL EQ 100MG HCL N61653 001 Nov DISC >A> @ EQ 100MG HCL N61653 001 Nov DISC >D> EQ 250MG HCL N61889 002 Nov DISC >A> @ EQ 250MG HCL N61889 002 Nov DISC >D> EQ 250MG HCL N61653 002 Nov DISC >A> @ EQ 250MG HCL N61653 002 Nov DISC >D> EQ 500MG HCL N61889 001 Nov DISC >A> @ EQ 500MG HCL N61889 001 Nov DISC URSODIOL CAPSULE; ORAL URSODIOL >A> AB LANNETT 300MG N79082 001 Dec 15, 2008 Nov NEWA ZALEPLON CAPSULE; ORAL ZALEPLON >A> AB WEST WARD 5MG N78147 001 Nov 25, 2008 Nov NEWA >A> AB 10MG N78147 002 Nov 25, 2008 Nov NEWA ZOLPIDEM TARTRATE TABLET; ORAL ZOLPIDEM TARTRATE >A> AB VINTAGE 5MG N78616 001 Nov 21, 2008 Nov NEWA >A> AB 10MG N78616 002 Nov 21, 2008 Nov NEWA
ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST
IBUPROFEN TABLET; ORAL IBUPROFEN >D> MUTUAL PHARM 200MG N72249 001 Jan 10, 1989 Nov CAHN >D> 200MG N71229 001 Apr 01, 1987 Nov CAHN >A> VINTAGE PHARMS 200MG N72249 001 Jan 10, 1989 Nov CAHN >A> 200MG N71229 001 Apr 01, 1987 Nov CAHN LORATADINE; PSEUDOEPHEDRINE SULFATE TABLET, EXTENDED RELEASE; ORAL LORATADINE AND PSEUDOEPHEDRINE SULFATE >D> ANDRX PHARMS 5MG;120MG N76208 001 Jan 28, 2004 Nov CAHN >A> WATSON LABS 5MG;120MG N76208 001 Jan 28, 2004 Nov CAHN NAPROXEN SODIUM TABLET; ORAL NAPROXEN SODIUM >A> AMNEAL PHARMS EQ 200MG BASE N79096 001 Dec 16, 2008 Nov NEWA NONOXYNOL-9 SPONGE; VAGINAL TODAY >D> + ALLENDALE 1GM N18683 001 Apr 01, 1983 Nov CAHN >A> + PAV NOVA 1GM N18683 001 Apr 01, 1983 Nov CAHN